Impact of CRISPR interference on strain development in biotechnology

Area of Science:

• Molecular Biology
• Biotechnology
• Genetic Engineering

Background:

• Genetic perturbation systems are crucial for metabolic engineering, drug discovery, and identifying biotechnological targets.
• CRISPR interference (CRISPRi) is a gene expression modulation system derived from the CRISPR-Cas9 technology.
• It utilizes a catalytically inactive Cas9 protein (dCas9) guided by sgRNA to bind DNA and inhibit transcription.

Purpose of the Study:

• To review the CRISPR interference (CRISPRi) system for gene expression control.
• To highlight its applications in bacterial physiology, metabolic engineering, and industrial biotechnology.
• To analyze the current limitations and future prospects of CRISPRi technology.

Main Methods:

• Utilizes a catalytically inactive CRISPR-associated protein 9 (dCas9).
• Employs single-guide RNA (sgRNA) to target specific DNA sequences.
• Interferes with transcription initiation or elongation without causing DNA double-strand breaks.

Main Results:

• CRISPRi enables precise gene knockdown for interrogating cellular physiology.
• Demonstrated success in metabolic engineering and strain development for industrial applications.
• Early-stage successes highlight the system's potential despite existing limitations.

Conclusions:

• CRISPRi is a versatile tool for gene regulation with significant potential in biotechnology.
• Further development is needed to overcome current limitations and expand its applications.
• Future perspectives suggest continued advancements in CRISPRi for biological research and industrial processes.